These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 8292873)

  • 1. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ; Scheer G; Muradin J; van der Does JA
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of temperature on plasma freezing under industrial conditions.
    Bravo MI; Grancha S; Jorquera JI
    Pharmeur Sci Notes; 2006 Aug; 2006(1):31-5. PubMed ID: 17694644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
    DePalma L; Criss VR; Luban NL
    Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation compared in stored whole blood with various nutrient-anticoagulant solutions.
    Knight JA; Searles DA; Blaylock RC
    Ann Clin Lab Sci; 1993; 23(3):178-83. PubMed ID: 8323251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
    Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
    Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6-hour exposure to 20 degrees C on the ATP content and other biochemical measures of CPDA-1 packed red cells.
    Ecker T; Hitzler WE
    Clin Lab; 2000; 46(5-6):291-3. PubMed ID: 10853239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of storage at 22 degrees C and citrate anticoagulation on the cytokine secretion of mononuclear leukocytes.
    Müller-Steinhardt M; Kirchner H; Klüter H
    Vox Sang; 1998; 75(1):12-7. PubMed ID: 9745148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C; Soute BA; Ates G; Brummelhuis HG
    Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability of blood coagulation factors in deep frozen fresh plasma by storage at -20 degrees C and -40 degrees C].
    Koerner K; Stampe D
    Infusionsther Klin Ernahr; 1984 Feb; 11(1):46-50. PubMed ID: 6706385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in thrombocyte volume in thrombocyte concentrates prepared from blood preserved with ACD or CPD as anticoagulants].
    Flego I; Nazor A; Grgicević D; Lupret L; Marchiotti I
    Lijec Vjesn; 1988; 110(3-4):75-8. PubMed ID: 3398688
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of delayed refrigeration on plasma factors in whole blood collected in CPDA-2.
    Sohmer PR; Bolin RB; Scott RL; Smith DJ
    Transfusion; 1982; 22(6):488-90. PubMed ID: 6815841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage of thawed cryoprecipitated AHF is better at room temperature than at 1 degree C to 6 degrees C for factor VIII content.
    Saxena S; Odono V; Francis R; Shulman IA
    Arch Pathol Lab Med; 1991 Apr; 115(4):343-5. PubMed ID: 1901483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Na3-citrate on the solubility of cryoprecipitate (citrate effect on cryoprecipitate).
    Faludi E; Harsányi V
    Haematologia (Budap); 1981; 14(2):207-14. PubMed ID: 6792005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.